CS
GHDX

Candriam SCA’s Genomic Health, Inc. GHDX Stock Holding History

Candriam SCA’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-30,765
Closed -$1.78M – 835
2019
Q2 		$1.78M Buy
30,765
+3,400
+12% +$201K 0.02% 537
2019
Q1 		$1.92M Buy
27,365
+9,616
+54% +$713K 0.02% 508
2018
Q4 		$1.14M Buy
17,749
+749
+4% +$52.5K 0.02% 563
2018
Q3 		$1.19M Sell
17,000
-23,000
-58% -$1.35M 0.02% 591
2018
Q2 		$2.02M Sell
40,000
-34,000
-46% -$1.35M 0.03% 485
2018
Q1 		$2.32M Sell
74,000
-15,000
-17% -$498K 0.04% 449
2017
Q4 		$3.04M Sell
89,000
-10,000
-10% -$319K 0.05% 374
2017
Q3 		$3.18M Hold
99,000
– – 0.06% 366
2017
Q2 		$3.22M Buy
99,000
+4,000
+4% +$127K 0.06% 361
2017
Q1 		$2.99M Buy
95,000
+8,000
+9% +$237K 0.06% 366
2016
Q4 		$2.56M Buy
87,000
+8,000
+10% +$244K 0.06% 321
2016
Q3 		$2.29M Buy
79,000
+16,000
+25% +$446K 0.06% 334
2016
Q2 		$1.63M Sell
63,000
-37,000
-37% -$983K 0.04% 346
2016
Q1 		$2.46M Sell
100,000
-28,000
-22% -$768K 0.06% 292
2015
Q4 		$4.51M Sell
128,000
-46,400
-27% -$1.24M 0.12% 192
2015
Q3 		$3.69M Sell
174,400
-9,600
-5% -$247K 0.09% 245
2015
Q2 		$5.11M Buy
184,000
+73,000
+66% +$2.06M 0.11% 237
2015
Q1 		$3.39M Sell
111,000
-9,000
-8% -$286K 0.07% 316
2014
Q4 		$3.84M Buy
+120,000
New +$3.91M 0.08% 280

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Candriam SCA's GHDX Position: Q3 2019 in Review

Candriam SCA sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 30,765 shares — an estimated $1.78M sold.

Candriam SCA first reported a position in GHDX in Q4 2014 and held it in 19 quarters. The position peaked at $5.11M in Q2 2015. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Candriam SCA reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Candriam SCA sold 30,765 Genomic Health, Inc. shares in Q3 2019, an estimated $1.78M.
  • Candriam SCA first reported a position in Genomic Health, Inc. in Q4 2014 and held it in 19 quarters.
  • Candriam SCA's Genomic Health, Inc. position peaked at $5.11M in Q2 2015.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.